The Hyderabad, India based firm announced it would add finished dosage form manufacturing capacity at the facility in Chantilly, Virginia earlier this year.
Granules gave more details of the project this week, explaining that it will spend $35m (€31m) on the expansion adding that it will create 102 new jobs.
Granules bought the plant from Valeant in 2014.
The firm said it “is conducting research and development to formulate products, and intends to manufacture products in the location as well.”
The expansion is backed by the Virginia Economic Development Partnership, which provides consultative services and funding to companies creating jobs. According to Virginia Business Granules is eligible to receive $750 per job.
The project is the third expansion Granules has announced this year.
In February, it said it will build an API production facility in Bonthapally, Telangana and increase capacity at a plant in Gagillapur where it produces pharmaceutical formulation intermediates (PFIs).
At the time a Granules spokesman told us “existing capacities are not sufficient to meet customer demand” adding the new and expanded facilities will supply both local and international markets.